Synoglim MV 3.3 Tablet SR
By Synoglim MV
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(3mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Synodic Lifesciences Pvt Ltd
PG-665,Sangam Vihar,Near Maya Goel School,New Delhi 110062

Expires on or after
September, 2025

liver
When it comes to using Synoglim MV 3.3 Tablet SR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Synoglim MV 3.3 Tablet SR. It is advisable to consult your doctor before starting this medication. Typically, Synoglim MV 3.3 Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease.

kidney
Synoglim MV 3.3 Tablet SR may not be safe for individuals with kidney disease. It is advised to avoid using this medication if you have kidney issues. Consulting with your doctor is recommended. Avoid in severe kidney disease cases.

alcohol
It is not safe to drink alcohol while taking Synoglim MV 3.3 Tablet SR.

driving
When your blood sugar levels are too low or high, it can impact your driving ability. Avoid driving if experiencing these symptoms.

pregnancy
It is important to be cautious when using Synoglim MV 3.3 Tablet SR during pregnancy. Limited human studies suggest potential harm to the developing baby, as observed in animal studies. Your doctor will evaluate the benefits and risks before prescribing it to you. Please consult your doctor regarding its use during pregnancy.

breastfeeding
Synoglim MV 3.3 Tablet SR may not be safe for breastfeeding. Limited data indicates the drug could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹220
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024